Mae’r llyfryn hwn yn fersiwn Cymraeg/Saesneg o’n canllaw i ddynion sydd wedi cael diagnosis o ganser y prostad yn ddiweddar. Mae lle ynddo i gofnodi manylion y diagnosis, dewisiadau triniaeth a chysylltiadau allweddol. PDF yw'r fersiwn Cymraeg yn unig.

Last updated: March 2014
To be reviewed: March 2016


  • Lifetime risk of cancer. Cancer Research UK., accessed January 2014
  • Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 2003;91:789–94.
  • Statistic calculated by Prostate Cancer UK using the current probability method using PHE and ONS data for England and Wales.
  • Giovannucci E, Liu Y, Platz EA, et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121(7):1571–78.
  • Orsini N, Bellocco R, Bottai M, et al. A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 2009;101(11):1932–38.
  • Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008;67(3):253–56.
  • Ma RW, Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet 2009;22(3):187–99.
  • Allen NE, Key TJ, Appleby PN, et al. Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2008;98(9):1574–81.
  • Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: A meta-analysis. J Natl Cancer Inst 2005;97(23):176877.
  • Ford D, Easton D, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet1998;62(3):676–89.
  • Burford DC, Kirby M, Austoker J. Prostate Cancer Risk Management Programme Guide No 2. Information for primary care: PSA testing in asymptomatic men. NHS Cancer Screening Programmes 2010. Available from
  • Holmstrom B, Johansson M, Bergh A, et al. Prostate specific antigen for early detection of prostate cancer: longitudinal study. BMJ 2009;339:b3537.
  • Berney DM. The case for modifying the Gleason grading system. BJU Int 2007;100(4):725–26.
  • Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. European Association of Urology, March 2013. Available at
  • National Institute for Health and Clinical Excellence (NICE). Prostate cancer: diagnosis and treatment. Clinical guideline 175. January 2014. Available from
  • Payne H. Management of locally advanced prostate cancer. Asian J Androl 2009;11(1):81–87.
  • Warde P, Mason M, Ding K, et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011;378(9809):2104–11.
  • Widmark A, Klepp O, Solberg A, et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009;373(9660):301–8.
  • National Institute for Health and Clinical Excellence (NICE). Low dose rate brachytherapy for localised prostate cancer. Interventional Procedure Guidance 132. 2005. Available from
  • National Institute for Health and Clinical Excellence (NICE). High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer. Interventional Procedure Guidance 174. 2006. Available from
  • Johansson J-E, Andren O, Andersson SO. Natural history of early localised prostate cancer. JAMA 2004;291(22):2713–19.
  • Crawford ED. Understanding the epidemiology, natural history and key pathways involved in prostate cancer. Urology 2009;73(5):S4–10.
  • Mishra SI, Scherer RW, Snyder C, et al. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012;8:CD008465.
  • Hedestig O, Sandman PO, Tomic R, Widmark A. Living after external beam radiotherapy of localized prostate cancer: a qualitative analysis of patient narratives. Cancer Nurs 2005;28(4):310–17.

Order printed copies of this publication

Before you order we would like to know who you are, and why you are ordering printed copies.

Download digital versions of this publication